Shell to Sell Permian Assets to ConocoPhillips for $9.5 Billion 

The sale is one of the biggest recent transactions in the shale patch as large oil companies come under increasing pressure to diversify beyond fossil fuels.

APA Rivals Brookfield Bid for AusNet 

APA Group set a deadline of one week for AusNet Services Ltd. to allow due diligence access after saying it is willing to trump an existing takeover proposal made by Brookfield Asset Management.

Honeywell at Odds With Asbestos Trust Over Bankruptcy Deal 

Honeywell International is locked in a standoff over asbestos payments with a bankruptcy trust that has accused the industrial conglomerate of "bullying and extortionate tactics" to settle injury liabilities for less than full value.

Shopping Online Is Getting More Expensive 

FedEx will raise shipping rates at the fastest pace in nearly a decade, adding to pressure on retailers to pass costs to customers.

SEC Is Investigating Activision Blizzard Over Workplace Practices, Disclosures 

Federal regulators have launched an investigation into Activision Blizzard, including how the videogame company handled employees' allegations of sexual misconduct and workplace discrimination.

GM to Replace Batteries in Recalled Chevy Bolts 

Dealerships are scheduled in mid-October to begin fixing Chevrolet Bolts that were recalled for fire risk, although many owners of the electric car likely will have to wait months.

Pfizer, BioNTech Say Vaccine Is Safe for Young Children 

The companies said the Covid-19 vaccine generated levels of antibodies that were similar to those of younger adults. Pfizer will seek emergency use authorization in the U.S. as early as the end of the month.

Freshworks Shouldn't Spoil on Delivery 

The cloud-software company's IPO should stand out for its reasonable valuation and path to profitability.

Twitter to Pay $809.5 Million to Settle Securities Suit 

The consolidated class-action securities lawsuit alleged the social-media company deliberately misled investors about user engagement in 2015.

AstraZeneca Breast Cancer Drug Found to Reduce Risk of Dying 

The drug maker said Enhertu significantly reduced the risk of death or disease progression in women with advanced disease in a large clinical trial, the latest sign that its push into oncology is starting to pay off.


(END) Dow Jones Newswires

September 21, 2021 03:15 ET (07:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.